ZLAB Zai Lab
- 15.910
- +0.170+1.08%
- 15.910
- 0.0000.00%
Zai Lab News
Zaiding Pharmaceutical (09688.HK) plans to hold a board meeting on May 9 (Hong Kong time) to approve the first quarter results
Gelonghui, April 26, 丨 Zaiding Pharmaceutical (09688.HK) announced that the Board Review Committee will review and approve (including) the unaudited quarterly results (“First Quarter Results”) of the Company and its subsidiaries for the 3 months ended March 31, 2024, prepared in accordance with US GAAP and applicable rules of the US Securities and Exchange Commission (“First Quarter Results”). If the first quarter results are approved by the Audit Committee, the company will do so on Wednesday, May 8, 2024 (US)
再鼎醫藥：審核委員會行動通告及2024年第一季度業績公告的發佈日期
Zai Lab Files Automatic Ordinary Shares Offering
Express News | Zai Lab Ltd : JP Morgan Cuts Target Price to $38 From $44
Asian Equities Traded in the US as American Depositary Receipts Remain Flat in Wednesday Trading
After opening the trading session in positive territory, Asian equities traded in the US as American depositary receipts fell flat Wednesday morning, declining 0.061% to 1,823.73 on the S&P Asia 50 AD
Press Release: Zai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024
Zai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024 - Company to Host Conference Call and Webcast on May 9, 2024, at 8:00 a.m. ET (8:00 p.m. HKT) SHA
Express News | Zai Lab Ltd : Jefferies Cuts Target Price to $38 From $50
Zai Lab Executives to Maintain Current Shareholdings
Zai Lab CEO, Others 'Do Not Anticipate' Selling Company Shares in Remainder of 2024
Zai Lab (ZLAB) said Thursday that Chief Executive Officer Samantha Du and some others on executive management team have agreed that they "do not anticipate" selling any company shares through the rema
Zai Lab Statement on Executive Management Team's Agreement on Share Activities
The Executive Officers of Zai Lab Limited (NASDAQ:ZLAB, HKEX: 9688)), Samantha Du, Josh Smiley, Rafael Amado, Harald Reinhart, Yajing Chen, F. Ty Edmondson, as well as Jonathan Wang, today announced that they have each
Zai Lab Changes Record Date
Zai Lab (HKG:9688) said it changed the ordinary share record date and the ADS record date, according to a Wednesday filing on the Hong Kong bourse. The ordinary share record date changed to Thursday,
Analysts' Opinions Are Mixed on These Healthcare Stocks: Inozyme Pharma (INZY), Zai Lab (ZLAB) and Idexx Laboratories (IDXX)
Zai Lab(ZLAB.US) Officer Sells US$31,157.92 in Common Stock
$Zai Lab(ZLAB.US)$ Officer Smiley Joshua L sold 1,988 shares of Common Stock on Apr 4, 2024 at an average price of $15.673 for a total value of $31,157.92.Source: Announcement What is statement of cha
Zai Lab(ZLAB.US) Officer Sells US$32,991.67 in Common Stock
$Zai Lab(ZLAB.US)$ Officer Reinhart Harald sold 2,105 shares of Common Stock on Apr 4, 2024 at an average price of $15.673 for a total value of $32,991.67.Source: Announcement What is statement of cha
Zai Lab(ZLAB.US) Officer Sells US$13,243.69 in Common Stock
$Zai Lab(ZLAB.US)$ Officer Chen Yajing sold 845 shares of Common Stock on Apr 4, 2024 at an average price of $15.673 for a total value of $13,243.69.Source: Announcement What is statement of changes i
Zai Lab(ZLAB.US) Officer Sells US$30,593.7 in Common Stock
$Zai Lab(ZLAB.US)$ Officer Amado Rafael sold 1,952 shares of Common Stock on Apr 4, 2024 at an average price of $15.673 for a total value of $30,593.7.Source: Announcement What is statement of changes
Zai Lab(ZLAB.US) Officer Sells US$19,497.21 in Common Stock
$Zai Lab(ZLAB.US)$ Officer Edmondson Frazor Titus III sold 1,244 shares of Common Stock on Apr 4, 2024 at an average price of $15.673 for a total value of $19,497.21.Source: Announcement What is state
Zai Lab Executive Acquires Shares Worth $113,605, Sells for $31,157
Zai Lab Grants Share Options, Restricted Share Units to Eligible Personnel
Zai Lab (HKG:9688) granted share options and restricted share units to eligible employees under its 2022 equity incentive plan, according to a Friday filing with the Hong Kong bourse. The company gran
Zaiding Pharmaceutical (09688.HK): Grant of share options and restricted share units
Gelonghui, April 5, 丨 Zaiding Pharmaceutical (09688.HK) announced that on April 1, 2024 (US Eastern Time), the company granted 345 grantees the right to subscribe for a total of 1,448,500 American Depositary Shares and granted 509 grantees restricted share units involving a total of 1.364,800 American Depositary Shares; and on April 3, 2024 (US Eastern Time), the company granted Dr. Du Ying a total of 5331,000 shares in accordance with the 2022 equity incentive plan Depository Share options and to Du Ying
Analysis
Price Target
No Data
